HEART REMODELING AT DIALYSIS PATIENTS
Abstract
Aim - studying of frequency of a left ventricular hypertrophy (LVH) and changes of heart geometry depending on level of blood pressure at dialysis patients. Material and methods. 40 dialysis patients have been divided into 3 groups depending on level of blood pressure (BP): hypotonics (BP = 100/60 mmHg. and lower), normotonics (BP = less than 139/89 mmHg.) and hypertensive patients (BP = 140/90 mm Hg. and higher). According to EchoKG LVH it is diagnosed for 55 % of patients. Results. Thus, among dialysis patients eccentric type- of LVH is more often. Severe anemia at hyperten sive persons significantly increases IMMLV. Great liquid volume in interdialysis period, especially at hypotonics, leads to a volume left ventricular overload.
Keywords:
hemodialysis, anemia, heart remodeling.References
1. Волгина Г.В. Клиническая эпидемиология кардиоваскулярных нарушений при хронической почечной недостаточности //Нефрология и диализ. 2000;том 2; №132: С.25-32.
2. Herzog С.А. Dismal long-term survival of dialysis patients after acute myocardial infarction: can we alter the outcome//Nephrol.Dial.Transplant.2002; 17(1): pp.7-10.
3. Paolettti P., Cassottana P., Bellino D. et al. Left ventricular geometry and adverse cardiovascular events in cronic hemodialysis patiens on prolonged therapy with ACE inhibitors// Am. J. Kidney Dis. 2002; 40(4): pp.728-736.
4. Беленков Ю.Н., Марев В.Ю. Принципы рационального лечения сердечной недостаточности. М. 2000г
5. Мареев В.Ю. Ингибиторы антиотензинпревращающего фермента в лечении больных коронарной болезнью сердца. Взгляд 2003 года // Кардиология. 2003; том 12, С. 4- 14.
6. Mancia G., De Backer G., Dominiczak A. et al. Management of arterial hypertension of the European Society of Hypertension. European Society of Cardiology. 2007 Guidelines for the management of Arterial Hypertension :The Task Force for the management of Arterial Hypervision of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)// J. Hyper- 2007; 25: pp. 1105-1187.
7. Devereux R.B., Reichek N. Echocardiographic deternation of left ventricular mass in man: anatomic valida- non of the method// Circulation. 1977; 55: pp.613-618.
8. Levy D., Garrison R.J.et al. Prognostic implications of echocardographically determined left ventricular mass in Framingham Heart Study// N. Engl. J. Med. 1990; 322: pp. 1561-1566.
9. Wanic-Kossowska М., Lehman P. Left ventricular hypertrophy in patients with chronic renal failure treated by hemodialysis // Pol. Arch. Med. Wewn. 2002; 107 (6): pp. 539-546.
10. Kutyrina I.М., Rudenko T.E., Shvetsov M. Iu., Kushnir W. The role of major vessels remodeling in development of left ventricular hypertrophy in patients with predialysis stage of chronic renal failure //Ter. Arkh. 2008; 80(6): pp. 37-41.
11. Grossman W. Cardiac hypertrophy: useful adaptation or pathologic process?// Am. J. Med. 1980; 69 (4): pp. 576-584.
12. Rossert J, Froissart M. Role of anemia in progression of chronic kidney disease. Semin Nephrol // 2006;26: pp. 283-289.
13. Iseki K, Kohagura K. Anemia as a risk factor for chronic kidney disease// Kid.Int. 2007; 72: S4-S9.
14. Stojimirovic B., Petrovic D., Obrenovic R. Left ventricular hypertrophy in patients on hemodialysis: importance of anemia // Med. Pregl. 2007; 60 (2): pp. 155-159
15. Romasheva E.P., Davydkin I.L. Left ventricular remodeling in outpatients with chronic renal failure treated with hemodialysis.// Ter. Arkh. 2009; 81 (1): pp. 21-24.
